6969 — Transcene Income Statement
0.000.00%
Last trade - 00:00- TWD1.07bn
- TWD1.78bn
- TWD200.22m
Annual income statement for Transcene, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Revenue | |||
| Total Revenue | 190 | 125 | 200 |
| Cost of Revenue | |||
| Gross Profit | 70.1 | 22.6 | 20 |
| Selling / General / Administrative Expenses | |||
| Research And Development | |||
| Total Operating Expenses | 203 | 218 | 276 |
| Operating Profit | -12.9 | -93.3 | -75.7 |
| Gain / Loss on Sale of Assets | |||
| Total Net Non Operating Interest Income / Expense | |||
| Other Net Non Operating Costs | |||
| Net Income Before Taxes | 8.7 | -95.5 | -88.1 |
| Provision for Income Taxes | |||
| Net Income After Taxes | 6.89 | -87.5 | -78.9 |
| Net Income Before Extraordinary Items | |||
| Net Income | 6.89 | -87.5 | -78.9 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Diluted Net Income | 6.89 | -87.5 | -78.9 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | 0.194 | -2.43 | -2.15 |
| Dividends per Share |